Tirzepatide 99% White Powder Raw peptide powder
2103 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
shanghai
Tai Hui
1g,10g ,50g,100g,1kg
Yes
2024-09-29
Tirzepatide,Sermaglutide,Retatrutide,GHRP-6,MTII,Melanotan II
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Sermaglutide,Retatrutide,GHRP-6,MTII,Melanotan II
-
Location:
Unit 10-1009, Building 1, No. 7 Consulate Road, Wuhou District, Chengdu City, Sichuan Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
10 days
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
-
Year of Establishment:
2021
-
-
Inquiry History2103 Inquiries
Country Product Purchase Quantity Date Posted 
Brazil
Tirzepatide
100 G Oct 28, 2026 
Belgium
Tirzepatide
10 MG Oct 28, 2026 
United States
tirzepatide
100 MG Oct 28, 2026
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026 
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026 
Slovakia
Tirzepatide
1 G Oct 26, 2026 
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026 
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026 
Peru
tirzepatide
10 MG Oct 21, 2026 
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026 
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026 Post an enquiry for this product
More from this Seller
-
-
![Semaglutide 99% White Powder Raw peptide powder 1g 10g 1kg]( "Semaglutide 99% White Powder Raw peptide powder 1g 10g 1kg")
-
Semaglutide 99% White Powder Raw peptide powder 1g 10g 1kg
Pharmaceutical Grade / 99%
-
